Novo Nordisk stops two cardiovascular studies aimed at lowering inflammation
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
Amgen Bets on MrBeast, Novo Builds a Thames Maze: Pharma’s Marketing Reckoning — BigGo Finance
Pharma is no longer hiding. In July 2026, Novo Nordisk built a public maze along the River Thames…